Rigel reported net income of $17.3 million, or $0.93 basic and $0.88 diluted per share, compared to $59.6 million, or $3.33 basic and $3.28 diluted per share, for the same period of 2025. As noted ...

Revolution Medicines (NASDAQ:RVMD) said its second-quarter 2026 results reflected continued investment in late-stage cancer ...

Baron Capital, an investment management company, released its Q2 2026 investor letter for the “Baron Health Care Fund”. A ...

U.S. FDA accepted daraxonrasib New Drug Application for review for previously treated metastatic pancreatic cancer following unprecedented Phase ...

GRIMESLAND, Pitt County — The Grimesland Volunteer Fire Department is mourning the death of charter member Paul ...

Collaboration with Lupvindol Biosciences will initially target companion-animal oncology and chronic pain managementSplash retains ownership of ...

MENLO PARK, Calif., Aug. 5, 2026 /PRNewswire/ -- GRAIL, Inc. (Nasdaq: GRAL), a healthcare company whose mission is to detect cancer early when it can be cured, today reported business and financial ...

The Kinston Police Department is asking for the public’s help identifying a vehicle and people connected to a hit-and-run ...

The real story of pre-Google search is not that early engines were inferior. It’s that they reflected a different Internet ...

Key Points Interested in Biodesix, Inc.? Here are five stocks we like better. Revenue increased 34% year over year to $26.9 ...

Total revenue of $73 million in 2Q26, a 92% year-over-year increase – – Revuforj® (revumenib) net revenue of $54.7 million in 2Q26, a 91% year-over-year increase – – Niktimvo™ (axatilimab-csfr) net ...

Key Points Interested in Trevi Therapeutics, Inc.? Here are five stocks we like better. Trevi launched two trials for ...